GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2022 Earnings Conference Call August 1, 2022 4:30 PM ET Company Participants David Dodd – Chairman and Chief Executive Officer Mark Reynolds – Chief Financial Officer Mark Newman – Chief Scientific Officer John Sharkey – Head, Business Development Conference Call Participants Jason McCarthy - Maxim Group Jeff Kraws - Crystal Research Kumarguru Raja - Brookline Capital Markets Operator Good afternoon and welcome everyone to the GeoVax Second Quarter 2022 Corporate Update Ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39563 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) of incorporation or organization) Delaware 8 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) of incorporation or organization) Delaware 87-0455038 (State or other jurisdiction (IRS Employer Identification No.) 1900 Lake Pa ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q4 2021 Earnings Conference Call March 9, 2022 4:30 PM ET Company Participants Jules Abraham - CORE, Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Reynolds - Chief Financial Officer Mark Newman - Chief Scientific Officer John Sharkey - Head, Business Development Conference Call Participants Jason McCarthy - Maxim Group Operator Good afternoon. And welcome everyone to the GeoVax Fourth Quarter Year End 2021 Corporate Update Call. I am Chuck with Cho ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 001-39563 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of 87-0455038 (IRS Employer Identification Number) 1900 Lake Park ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q3 2021 Earnings Conference Call November 11, 2021 4:30 PM ET Company Participants Jules Abraham - Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer John Sharkey - Head, Business Development Don Diamond - Professor, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Conference Call Participants Jason McCarthy - Maxim Group Operator Good afternoon and we ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q 1900 Lake Park Drive, Suite 380 Smyrna, Georgia 30080 (Address of principal executive of ices) (Zip Code (State or other jurisdiction (IRS Employer Identification No.) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q2 2021 Earnings Conference Call August 11, 2021 4:30 PM ET Company Participants Jules Abraham - CORE, Investor Relations David Dodd - Chairman and Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Jeffrey Kraws - Crystal Research Operator Good day and welcome to the GeoVax Second Quarter 2021 Corporate Update Call. I am [Gran], with Chorus Call and will facilitate ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39563 GEOVAX LABS, INC. (Exact name of registrant as specified in its charter) Delaware 87-0455038 (State or other jurisdiction (IRS Employer Id ...

GeoVax Labs, Inc. (NASDAQ:GOVX) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Jules Abraham - Director of Public Relations, CORE IR David Dodd - Chairman & Chief Executive Officer Mark Newman - Chief Scientific Officer Mark Reynolds - Chief Financial Officer Conference Call Participants Jason McCarthy - Maxim Group Kumar Raja - Brookline Capital Markets Jeffrey Kraws - Crystal Research Operator Good afternoon, and welcome everyone to the GeoVax First Quarter 2021 Conference Ca ...